Abstract: In order to obtain a persuasive explanation for the beneficial clinical effect of cryotherapy on keloids, we developed a reproducible model to apply freezing temperatures on cell cultures, and investigated their influence on proliferation, viability, synthetic activity and differentiation of dermal fibroblasts in vitro. Cell cultures were established from 13 untreated keloids and 10 healthy skin specimens matched for age and skin localization to the donors. No significant influence of cell freezing on the proliferation rates of both keloidal and normal fibroblasts was documented, but mechanical cell destruction with a wide variation in lethality rates (29% average lethal effect on keloidal fibroblasts and 41% on normal ones) was observed. When comparing specimens of keloidal and normal tissue derived from the same four donors, the keloidal fibroblasts were similar regarding their synthetic activity but presented enhanced tenascin-C expression compared with the normal fibroblasts. After cryotherapy, delayed collagen III increase was detected in both cell types (P ¼ 0.03). The collagen III/collagen I ratio increased from 1.6 to 2.8 in the keloidal and only from 1.9 to 2.2 in the normal fibroblasts after subcultivation. Normal fibroblasts exhibited a significantly lasting increase in fibronectin synthesis after freezing (P ¼ 0.03). The intensity of staining against tenascin-C was decreased in five of nine keloidal fibroblast cultures after cryotherapy (P < 0.05) but increased in four of five normal fibroblast cultures (P ¼ 0.016), so that the intensity of tenascin-C staining after freezing became identical in both cell types. Immunoblot studies in four patients and two controls confirmed a temporary decrease of tenascin-C in keloidal but not in normal fibroblasts immediately after freezing. Significantly decreased staining with two markers of myogenic differentiation, myosin in keloidal fibroblasts (P ¼ 0.002) and desmin (P ¼ 0.007) in normal fibroblasts, could also be detected after treatment. In summary, with the help of a model for controlled cell freezing in vitro, cryotherapy was found to modify collagen synthesis and differentiation of keloidal fibroblasts.
Introduction
Keloids represent benign exuberant forms of scar formation. They consist of excessive amounts of thick, densely packed eosinophilic collagen bundles in a focal or irregular pattern and few fibroblasts (1, 2) . Clinically, they extend beyond the confines of the original wound, do not regress spontaneously, and tend to recur after excision (3) (4) (5) . Several therapeutic regimens have been used with contradictory results (3, (5) (6) (7) . Cryosurgery has been accepted as the current treatment of choice for keloids, because it is highly effective and does not induce recurrences (8, 9) . To elucidate the beneficial effects of cryotherapy on keloids, a standardized system for application of freezing temperatures on single-cell suspensions was developed, and their effects on proliferation, synthetic activity and differentiation of keloidal and normal dermal fibroblasts in vitro were investigated.
Materials and Methods

Fibroblast cultures
All experiments were approved by the Review Board of the University Medical Center Benjamin Franklin, The Free University of Berlin, Berlin, Germany. Primary fibroblast cultures were established from nine untreated keloids (six men, three women; duration of the disease was 1-7 years) and eight healthy skin specimens (three men, five women). Four patients donated both keloidal and healthy skin tissue. Skin specimens were identical regarding age (15-58 years) and localization (earlobe, chest, shoulder and back) of the donors. Keloids had developed after injury, namely after ear piercing (n ¼ 1), surgical excision (n ¼ 3) and scarring acne (n ¼ 3). For Western blot studies, primary fibroblast cultures were established from four untreated keloids (two men, two women, aged 30-59 years). Keloids had developed after abdominal surgery. Normal fibroblasts cultures from skin specimens of two of the same patients (one man, one woman) served as controls. Fresh keloidal or healthy dermal tissue was isolated from the skin specimens by microscissors and left to attach onto culture dishes (Falcon, New Jersey, NJ). Two weeks later, primary fibroblast cultures were obtained as outgrowths from the dermal tissue. Tissue and cell cultures were maintained in Dulbecco's modified Eagle's medium (Biochrom, Berlin, Germany) supplemented with 5% fetal calf serum and antibiotics. All investigations were carried out in passages 3-5.
System of controlled application of freezing temperatures in vitro
To apply freezing temperatures to fibroblast cultures, a standardized system was developed that fulfilled the following requirements: constant low system temperature of at least À70 C, large contact surface of cell suspension to the cold generator to guarantee homogenous freezing, quick development of À25 C in the cell environment, slow thawing to increase cell damage, sterile conditions for further cultivation of the treated cells, and sufficient lethal effect on 25-50% of cells.
Fibroblasts were shock-exposed to precooled ethanol to À75 C for 2.5 min in a sterile cell-freezing tube filled with 1 ml of cell suspension and subsequently thawed slowly at room temperature. The lethal effect was quantified by trypan blue staining. Experiments were performed immediately after freezing and one passage later to distinguish between 'temporary early', 'late', and 'lasting' effects.
For Western blot studies, fibroblasts were frozen at À80 C for 20 min in their culture flasks supplemented with freezing medium composed of Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and 10% dimethyl sulfoxide. After the treatment procedure one half of the fibroblasts were lysed immediately, and the other half was cultivated for a further 7 days before lysing the cells.
Growth kinetics
Keloidal and normal fibroblasts were seeded in 96-well culture plates (Nunc, Wiesbaden, Germany) at a density of 0.5 Â 10 3 cells/well. Cell proliferation was assessed daily during the logarithmic phase of cell growth (days 2-6) by the 4-methylumbiliferyl heptanoate (MUH) fluorescence assay, and measured automatically, as previously described (10) . On the day of evaluation, the culture medium was removed, the cells were washed twice with phosphate buffered saline without Ca 2þ and Mg 2þ (PBS), and 100 ml of a 100-mg/ml MUH (Serva, Heidelberg, Germany) solution in PBS was added to each well. The plates were then incubated at 37 C for 30 min, and released fluorescence was read on a Titertek Fluoroscan II (Labsystems, Frankfurt, Germany). Results are given as absolute fluorescence units (AFU) of 6-plicate wells using 355-nm excitation and 460-nm emission filters. The population doubling times (PDT) were calculated as previously described (11) .
Synthesis of collagen I, III, IV and fibronectin
To investigate collagen I, III, IV and fibronectin synthesis, keloidal and normal fibroblast cultures of the same passage were grown to subconfluency in 6-well culture plates (Falcon). Briefly, the culture medium was removed, the cells were washed twice with PBS and incubated in serum-free medium supplemented with 50 mg/ml of ascorbic acid and 100 mg/ml of b-aminopropionitrile for 24 h. The supernatants were then collected, mixed with 40 ml/ml of ethylene diamine tetraacetate, 1 ml/ml of N-ethylene maleinide and 0.8 ml/ml of phenyl-methyl-sulfonyl fluoride to inhibit enzyme activity, and were frozen at À20 C until use. Collagen I, III, IV and fibronectin levels were measured by a modified direct enzyme-linked immunosorbent assay (12) . 96-well polystyrene plates were coated with pure supernatant 100 ml/well for collagen evaluation or with supernatant diluted 1 : 1 and fresh serum-free medium for fibronectin measurement for 16 h at 37 C. Collagen I, collagen III, collagen IV (gifts from Dr Schuppan, Berlin, Germany) and fibronectin (Biomol, Hamburg, Germany) were used as standards and fresh serum-free medium as the control. The plates were thereafter treated with 1 mg/ml of bovine serum albumin in PBS for 1 h at 20 C to block unspecific binding of the antigen, and incubated in 4-plicate with primary monoclonal antibodies (mAb; 100 ml) against collagen I (Z14/3, 1 : 10 000), collagen III (mPIII/a, 1 : 1000), collagen IV (IVb/4, 1 : 1000) (all kindly provided by Dr Schuppan) or fibronectin (1 : 1000; Biomol) for 1 h at 20 C. To intensify the reaction, a multistep detection technique was used. Biotin-labeled IgG (1 : 500; Sigma, Deisenhofen, Germany) was added for 1 h at 20 C followed by extravidine peroxidase solution (1 : 500; Sigma) for 1 h and by peroxidase antiperoxidase complex (1 : 500; Sigma) for 70 min to all mAbs except collagen III. Between these stages, washing with 0.05% Tween in PBS was performed. The amount of antibodies bound was visualized by incubation in a solution containing ortho-diphylene-diamine dichloride (13) , and the reaction was stopped by sulphuric acid (25%). Optical density was measured at 490 nm in a Dynatech ELISA reader (Ru¨ckersdorf, Germany). Protein amounts were referred to as cell numbers of the original wells.
Immunocytochemistry
Immunocytochemical investigations were performed using the mAb against the extracellular matrix proteins collagen I (KmPIa, 1 : 150), collagen III (mPIIIa/2, 1 : 100), collagen IV (Nca/2, 1 : 100), collagen VI (98/6 1 : 1000) (all kindly provided by Dr Schuppan), fibronectin (1 : 800; Dako, Hamburg, Germany) and laminin (980/2, 1 : 50; Dr Schuppan); as well as against the recently described proteins tenascin-C (1 : 50; Biomol) and undulin/collagen XIV (400 k/2, 1 : 100; gift from Dr Schuppan) (14-16); the integrins collagen I receptor (VLA a2, 1 : 50) and fibronectin receptor (VLA a5, 1 : 50) (both from Dianova, Hamburg, Germany); a-smooth muscle actin (1 : 100; Sigma), desmin (1 : 100; Dako) and myosin (1 : 100; Sigma) as markers for myogenic differentiation; dermal elastic fibers (1 : 100; Dianova); and Ki-67 (1 : 40; Dako); as a proliferation marker.
Two thousand cells were seeded in each well of modified 8-chamber culture vessels (Nunc) maintained in 300 ml of culture medium and left to grow for 4 days at 37 C with 5% CO 2 . The slides were then separated from the culture vessels, carefully washed with PBS, air-dried, and stored in sealed boxes at À20 C for up to 14 days. Before use, the slides were thawed slowly, fixed in 1% glutaraldehyde solution for 1 h, and treated in 0.2% Triton X-100-solution for 10 min at room temperature. Alkaline phosphatase antialkaline phosphatase staining was performed following established procedures (17) . The mAbs were diluted in RPMI 1640 medium (Gibco, Berlin, Germany). Briefly, the primary antibodies were incubated with the samples for 30 min and the specimens were then washed thoroughly in PBS. The sections were consequently incubated with IgG (Dianova) diluted 1 : 100 in a 1 : 1 mixture of human serum and RPMI 1640 medium for 30 min and then washed as described earlier. The immunoreactants were visualized by incubation in a solution containing naphthol salt, hexazotized new fuchsin and levamisole, counterstained with haematoxylin, and mounted in Kaiser's gelatin solution according to standard procedures. Negative controls, prepared by the same procedure but omitting the primary antibodies, were included.
The slides were viewed under a Leitz microscope (Gais, Switzerland). The distribution and intensity of staining in the tissue specimens was graded from (-) up to (þ þ þ). For evaluation of the fibroblast cultures the intensity of staining was compared, and five grades from 0 up to 4, corresponding to 'negative', 'weak', 'average', 'strong', and 'very strong' staining, were used for statistical analysis.
Western blot analysis and immunoblotting
Cells were lysed with M-Per mammalian protein extraction reagent (Pierce, Bonn, Germany). The total amount of protein was determined by the method of Bradford (18) . Samples containing 25 mg of total protein of the fibroblast lysates were proceeded to electrophoresis on SDS-Tris-acetate polyacrylamide gradient gels (3-7%) and transferred onto an Immobilon-P membrane (Millipore; Bedford, MA). Blots were blocked in PBS/0.1% Tween 20 containing 0.2% casein at 4 C overnight, and then incubated sequentially with anti-tenascin-C (N-19) goat polyclonal IgG antibody (Santa Cruz, Heidelberg, Germany) diluted 1 : 500 at room temperature for at least 1 h and consequently diluted 1 : 5000 with horseradish peroxidase-conjugated antigoat IgG antibody (Santa Cruz, Heidelberg, Germany) for 30 min. The immunoblots were then stripped and reprobed with an unrelated b-actin antibody (dilution 1 : 100000; Sigma). The labeled proteins were evaluated using the enhanced chemiluminescence system (ECL; Amersham, Freiburg, Germany). Tenascin-C band intensities were quantified densitometrically using the Fuji video imaging system TINA 2.0 (Du¨sseldorf, Germany).
Statistical analysis
Results are presented as median values with 25% and 75% ranges or as mean values + standard deviation. Statistical significance was calculated by the Student's t-test and the Mann-WhitneyWilcoxon U-test. Differences were considered as statistically significant at P < 0.05.
Results
Behavior of normal fibroblasts from patients with keloids and healthy donors
Normal fibroblasts from patients with keloids and healthy donors provided similar results in all experiments performed; therefore they were then pooled in a single control group.
Fibroblast proliferation and viability in vitro
Donor-dependent variation but overall similar patterns of cell proliferation were detected in the 
Cell freezing induced a sufficient degree of damage, with an average lethal effect on 29% of the keloidal fibroblasts and 41% of the normal fibroblasts. A wide variation of lethality rates was obtained, ranging between 9 and 86% of the treated cells. However, no significant influence of cell freezing on proliferation rates of both the keloidal and normal fibroblasts could be documented (Table 1) .
Synthesis of collagen I, III, IV and fibronectin
There was a wide donor-dependent variation in the synthetic activity of the fibroblast cultures: ranging from 9.8 + 2.4 to 42.9 + 11.0 ng/10 3 keloidal fibroblasts and 8. . Collagen III and collagen I comprised the major collagen types produced in both cell types with a collagen III/collagen I ratio of 1.6 for the keloidal and 1.9 for the normal fibroblasts. Only trace amounts of collagen IV were detected (< 3%) (Fig. 1) . In addition, similar fibronectin levels were produced by the keloidal and normal fibroblasts.
Cryotherapy did not influence the synthesis of collagen I in either cell type immediately or after subcultivation (Fig. 2a) . On the contrary, a late collagen III increase was detected in both cell types (P ¼ 0.03) (Fig. 2b) . The collagen III/collagen I ratio increased to 2.8 for the keloidal and 2.2 for the normal fibroblasts after subcultivation (Fig. 3) . Also, a trend for increased collagen IV synthesis was found in the keloidal fibroblasts (Fig. 2c) . At last, the normal, but not the keloidal, fibroblasts exhibited a significant permanent increase in fibronectin synthesis after freezing (P ¼ 0.03) (Fig. 2d) .
Immunocytological studies
Differentiation pattern of the keloidal fibroblasts in vitro corresponded to the pattern previously reported in keloid tissue (15) . In particular, significantly stronger staining with the mAb against tenascin-C was detected in the keloidal compared with the normal fibroblasts (P ¼ 0.003) ( Table 2 , Fig. 4a, b) . Six of nine keloidal fibroblast cultures showed very strong, one culture strong, and two cultures average staining, whereas all five examined normal fibroblast cultures exhibited average staining. Desmin, a marker for myogenic differentiation, presented a significantly stronger expression in the normal fibroblast cultures than in those of the keloids (P ¼ 0.014). In all examined normal fibroblast cultures, very strong staining was detected, while only three of nine keloidal fibroblast cultures expressed very strong and six of nine weak staining. No differences could be found in the staining patterns of further mAbs tested between the keloidal and normal fibroblasts.
The intensity of staining against tenascin-C in the keloidal fibroblasts was decreased in five of nine cultures after cryotherapy (P < 0.05) (Fig. 4b, c) . In contrast, tenascin-C was increased in four of five of the normal fibroblast cultures after treatment (P ¼ 0.016); so that the intensity of tenascin-C staining in keloidal and normal fibroblasts became identical after freezing (Table 2 ). In addition, a significant decrease in staining with the two markers of myogenic differentiation, myosin in the keloidal fibroblasts (P ¼ 0.002) and desmin (P ¼ 0.007) in the normal fibroblasts, could be detected after treatment.
Immunoblotting studies
Expressions of tenascin-C in the native fibroblasts, in the fibroblasts immediately after freezing, and in the cells frozen once and cultivated for a further 7 days were compared. Cell freezing caused an immediate marked decrease of tenascin-C expression in the keloidal fibroblasts of all patients tested (79 + 29%, range 37-99%, n ¼ 4; Fig. 5 ). This was a temporary effect, as tenascin-C expression returned to its initial levels 7 days after freezing. A repetition of freezing had no further effect on tenascin-C expression in the keloidal fibroblasts. In contrast, freezing did not immediately affect the expression of tenascin-C in the normal fibroblasts, whereas a slightly reduced tenascin-C expression at a range of 21-33% could be assessed 7 days after freezing (Fig. 6 ).
Discussion
Cryosurgery is considered the treatment of choice for keloids and hypertrophic scars (8, 9) , but its exact mechanism of action is still unknown. Mechanical tissue destruction (19, 20) and scar neovascularization (8) are likely to induce a beneficial effect; rarefaction of vessels and the resulting tissue hypoxia have been postulated to partially induce pathologic scar formation (21) . By developing a reproducible model of controlled freezing of cultured fibroblasts, we provide here the first evidence of the selective effects of freezing on the synthetic activity and differentiation of keloidal fibroblasts. The marked donor-dependent heterogeneity of fibroblast response to freezing confirmed previous observations (22) . On the other hand, the overall response to freezing supports a normalizing influence of cryotherapy on the altered synthetic activity of keloidal fibroblasts. Our in vitro findings regarding the characteristics of keloidal fibroblasts are in accordance with previous reports of unaltered proliferation rates (23) (24) (25) and an increased expression of tenascin-C (14,26), but could not confirm further increased metabolic activity (22, 27) . The latter discrepancy probably resulted from the following reasons: Abergel et al. (22) and Hunzelmann et al. (27) , who found increased collagen expression in keloidal compared with normal fibroblasts, have used skin specimens from different donors to establish keloidal and normal fibroblast cultures. In contrast, we compared the synthetic activity of keloidal and normal fibroblast cultures that were derived from the same four donors. This new finding may implicate a genetically determined level of fibroblast synthetic activity in keloid-prone skin. In addition, collagen synthesis is increased in some but not all keloids (28, 29) , a fact suggesting that keloids can be classified as either high or normal producers of collagen (21) . Freezing induced collagen III synthesis but was not able to reduce collagen I synthesis in keloidal fibroblasts like other successful therapeutic regimens, namely corticosteroids (30, 31) , and interferonalpha (32) . The collagen III/collagen I ratio therefore increased after freezing, which confirms the phenotype of a fresh scar (33) and the increased tissue elasticity and decreased solidity (34) observed in keloids after cryosurgery (8) .
An important finding of our studies was the reduction of the increased expression of tenascin-C Labeling with tenascin-C mAb is slightly stronger in keloidal than in normal fibroblasts and markedly decreases in keloidal fibroblasts after freezing. Table 2 . Immunocytological staining of keloidal and normal fibroblast cultures before and after freezing (keloidal fibroblast cultures, n ¼ 9; normal fibroblast cultures, n ¼ 5). Labelling intensity was graded as follows: negative ¼ 0; weak ¼ 1; average ¼ 2; strong ¼ 3; very strong ¼ 4.
Keloidal fibroblasts
Normal fibroblasts Untreated After freezing Untreated After freezing in keloidal fibroblasts after freezing. Tenascin-C is not only a marker for keloidal fibroblast differentiation in vitro (14) but is also likely to detect the response of keloids to therapeutic regimens. TGF-b1 is a potent inducer of tenascin-C (35, 36) . Interestingly, TGF-b1 is increased in keloids (37) and also induces fibronectin and collagen expression (38, 39) . Therefore, we assume that the defective negative feedback mechanism that characterizes keloidal fibroblasts (40, 41) , may regulate the production of tenascin-C being possibly a correlate of protracted fibrogenic activation. Cryotherapy is probably able to interfere at this level, inducing its normalizing effect on fibroblast activity. In contrast, normal fibroblasts either increased their tenascin-C expression after freezing, like they do in vivo at the early phase of wound healing (42), or they exhibited no change. Tenascin-C expression can be regulated by many different growth factors and hormones (43) . Furthermore, mechanical strain exerted by fibroblasts seems to induce the expression of tenascin-C (44). Keloids are characterized by mechanical strain, and the tenascin-C gene promoters contain 'stretchresponsive' enhancer regions with similarity to 'shear stress response elements' in other genes. As cryotherapy reduces clinically the mechanical strain of keloids (45) , it may reduce tenascin-C expression by an associated but still unknown early mechanism. Interestingly, glucocorticoids, which represent another therapeutic regimen for keloids, also reduce tenascin-C expression in wounded skin (46) . Whether the common anti-inflammatory effects of cryotherapy and glucocorticoids on keloid tissue (47) are involved in the reduction of tenascin-C expression remains unclear.
Further immunocytological investigations showed signs for myogenic differentiation of keloidal fibroblasts (48) , which was also reduced by freezing, indicating a possible additional effect of cryotherapy towards mainstream fibroblast differentiation.
In summary, our data show that keloidal fibroblasts in vitro exhibit several characteristics detected in keloidal tissue in vivo, despite wide donor-dependent variation of activity. With the help of a model for controlled cell freezing in vitro, cryotherapy was found to modify collagen synthesis and differentiation of keloidal fibroblasts towards a normal phenotype. Native, normal fibroblasts (= 100% expression), (B) normal fibroblasts immediately after freezing, and (C) normal fibroblasts 7 days after freezing (n ¼ 2). Freezing had no immediate influence on tenascin-C expression in the normal fibroblasts, whereas a reduced tenascin-C expression of 21% (woman) and 33% (man) could be assessed 7 days after freezing.
